Inmune Bio Inc. (INMB)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 90
-0.17
-8.2126%
$
53.7M Market Cap
- P/E Ratio
- Div Yield
796,500 Volume
-2.19 Eps
$ 2.07
Previous Close 
Want to track INMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
INMB Earnings Reports FAQ
What is the earnings per share (EPS) for INMB?
The current EPS is -2.19.
What is the company's earnings growth rate?
Inmune Bio Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Inmune Bio Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Inmune Bio Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for INMB at this time, as Inmune Bio Inc has no recent EPS data to calculate it.
